Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	regulation of modification of synaptic structure	PRMT8 MYO5B RHOB CDC42 EPHA4	9.25e-06	29	206	5	GO:1905244
GeneOntologyBiologicalProcess	modification of synaptic structure	PRMT8 MYO5B PFN2 RHOB CDC42 EPHA4	1.14e-05	51	206	6	GO:0099563
GeneOntologyBiologicalProcess	sexual reproduction	SETX USP9X ACR RPS6KA2 ADAM7 USP9Y H1-9P ITPR1 SYCP2 PSME4 MOV10L1 CCR6 TDRD6 MERTK WDR77 SHISA6 DNMT3B LAMP1 FANCL ACTR3 ZFY VIPAS39 IGF2R CTCF FSHB CCT8 CFAP61 RPA1 VPS13B	4.77e-05	1312	206	29	GO:0019953
GeneOntologyBiologicalProcess	gamete generation	SETX USP9X RPS6KA2 ADAM7 USP9Y H1-9P SYCP2 PSME4 MOV10L1 CCR6 TDRD6 MERTK WDR77 SHISA6 DNMT3B LAMP1 FANCL ZFY VIPAS39 IGF2R CTCF FSHB CFAP61 VPS13B	4.88e-05	982	206	24	GO:0007276
GeneOntologyBiologicalProcess	modification of postsynaptic structure	PRMT8 MYO5B PFN2 RHOB CDC42	5.96e-05	42	206	5	GO:0099010
GeneOntologyBiologicalProcess	regulation of modification of postsynaptic structure	PRMT8 MYO5B RHOB CDC42	6.14e-05	22	206	4	GO:0099159
GeneOntologyBiologicalProcess	postsynapse organization	EPHB3 MAP1B MYO5B USP9X NLGN3 FCGR2B SHISA6 CNKSR2 ACTR3 CDC42 AGRN EPHA4	7.73e-05	313	206	12	GO:0099173
GeneOntologyBiologicalProcess	immunoglobulin V(D)J recombination	EZH2 POLB PRKDC	1.12e-04	10	206	3	GO:0033152
GeneOntologyBiologicalProcess	regulation of synapse organization	EPHB3 PRMT8 MAP1B MYO5B USP9X NLGN3 FCGR2B ADGRL1 ACTR3 RHOB CDC42 AGRN EPHA4	1.47e-04	387	206	13	GO:0050807
GeneOntologyBiologicalProcess	dendritic spine organization	EPHB3 MYO5B NLGN3 FCGR2B ACTR3 CDC42 EPHA4	1.58e-04	115	206	7	GO:0097061
GeneOntologyBiologicalProcess	dendritic spine morphogenesis	EPHB3 MYO5B NLGN3 ACTR3 CDC42 EPHA4	1.61e-04	81	206	6	GO:0060997
GeneOntologyBiologicalProcess	regulation of synapse structure or activity	EPHB3 PRMT8 MAP1B MYO5B USP9X NLGN3 FCGR2B ADGRL1 ACTR3 RHOB CDC42 AGRN EPHA4	1.80e-04	395	206	13	GO:0050803
GeneOntologyBiologicalProcess	synapse organization	EPHB3 PRMT8 MAP1B MYO5B USP9X PFN2 NLGN3 FCGR2B SHISA6 CNTN4 ADGRL1 CNKSR2 ACTR3 RHOB PLXNA4 CDC42 AGRN EPHA4	1.87e-04	685	206	18	GO:0050808
Domain	ARM-type_fold	CEP104 STAG1 DOCK11 USP9X INTS1 UNC45A USP9Y ITPR1 PSME4 AP1B1 AP2B1 UBR4 XPO4 ECPAS PRKDC WDFY3	8.06e-07	339	200	16	IPR016024
Domain	-	GTF2IRD2 GTF2IRD2B GTF2I	4.80e-06	4	200	3	3.90.1460.10
Domain	SHR-BD	VPS13C VPS13A VPS13B	4.80e-06	4	200	3	IPR009543
Domain	VPS13_C	VPS13C VPS13A VPS13B	4.80e-06	4	200	3	PF16909
Domain	GTF2I	GTF2IRD2 GTF2IRD2B GTF2I	4.80e-06	4	200	3	PS51139
Domain	GTF2I	GTF2IRD2 GTF2IRD2B GTF2I	4.80e-06	4	200	3	PF02946
Domain	VPS13_C	VPS13C VPS13A VPS13B	4.80e-06	4	200	3	IPR031645
Domain	GTF2I	GTF2IRD2 GTF2IRD2B GTF2I	4.80e-06	4	200	3	IPR004212
Domain	SHR-BD	VPS13C VPS13A VPS13B	4.80e-06	4	200	3	PF06650
Domain	ARM-like	CEP104 SETX STAG1 USP9X UNC45A USP9Y PSME4 AP1B1 AP2B1 XPO4 ECPAS PRKDC WDFY3	7.22e-06	270	200	13	IPR011989
Domain	Autophagy-rel_C	VPS13C VPS13A VPS13B	1.19e-05	5	200	3	IPR015412
Domain	ATG_C	VPS13C VPS13A VPS13B	1.19e-05	5	200	3	PF09333
Domain	Chorein_N	VPS13C VPS13A VPS13B	6.51e-05	8	200	3	PF12624
Domain	VPS13_N	VPS13C VPS13A VPS13B	6.51e-05	8	200	3	IPR026854
Domain	Clathrin_b-adaptin_app_Ig-like	AP1B1 AP2B1	1.14e-04	2	200	2	IPR013037
Domain	-	AP1B1 AP2B1	1.14e-04	2	200	2	2.60.40.1150
Domain	-	CEP104 USP9X UNC45A PSME4 AP1B1 AP2B1 XPO4 ECPAS PRKDC WDFY3	1.45e-04	222	200	10	1.25.10.10
Domain	AP_complex_bsu_1_2_4	AP1B1 AP2B1	3.40e-04	3	200	2	IPR016342
Domain	VPS13	VPS13C VPS13A	3.40e-04	3	200	2	IPR026847
Domain	VPS13_mid_rpt	VPS13C VPS13A	3.40e-04	3	200	2	PF16910
Domain	VPS13	VPS13C VPS13A	3.40e-04	3	200	2	PF16908
Domain	VPS13_N2	VPS13C VPS13A	3.40e-04	3	200	2	IPR031646
Domain	VPS13_mid_rpt	VPS13C VPS13A	3.40e-04	3	200	2	IPR031642
Domain	B2-adapt-app_C	AP1B1 AP2B1	3.40e-04	3	200	2	PF09066
Domain	B2-adapt-app_C	AP1B1 AP2B1	6.75e-04	4	200	2	SM01020
Domain	B-adaptin_app_sub_C	AP1B1 AP2B1	6.75e-04	4	200	2	IPR015151
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DOCK11 USP9X RPS6KA2 DDN PFN2 ITIH1 NLGN3 AP1B1 AP2B1 CNTN4 UBR4 ARHGEF12 GRIA3 CNKSR2 KIF7 RHOC ACTR1A IGF2R CTCF CCT8 MACF1 WDFY3 RPA1 AGRN EPB41L2 SPATA13 LGI1 EPHA4	8.10e-12	963	211	28	28671696
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CEP104 STAG1 MAP1B MYO5B ADAM7 MRPS35 U2AF2 AP2B1 VPS13A GTF2IRD2 DTHD1 MNDA DNMT3B RARRES1 SLC25A4 SLC25A5 ZSWIM5 UBR4 GRIA3 ACTR3 USP8 GTF2IRD2B TBC1D31 PLXNA4 ACIN1 MACF1 EIF2AK4 PRKDC NGLY1 IL1R1 SPATA13 EPHA4	2.43e-10	1442	211	32	35575683
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	SETX DOCK11 VPS13C LAMA1 INTS1 CHN1 DNAH14 SARS1 DEFB121 VPS13A COL1A2 SLC25A5 UBR4 MYOM3 ICE1 ECPAS PLXNA4 CCT8 EEF1AKMT1 PRKDC RPA1 EPB41L2	9.82e-10	736	211	22	29676528
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ZC3H15 USP9X VPS13C MRPS35 U2AF2 UNC45A USP19 DHX15 SARS1 TXNDC5 GGCT TDRD6 DHX29 WDR77 SLC25A5 UBR4 IDH2 ECPAS ACTR3 ACTR1A GTF2I IGF2R CCT8 ACIN1 PRKDC RPA1 CDC42 EPB41L2	4.82e-08	1425	211	28	30948266
Pubmed	Sex differences in sex chromosome gene expression in mouse brain.	USP9X USP9Y KDM6A UTY ZFY	6.30e-08	18	211	5	12023983
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	USP9X UNC45A USP19 DHX15 SARS1 TXNDC5 AP1B1 AP2B1 WDR77 SLC25A5 UBR4 ECPAS ACTR1A GTF2I CCT8 PRKDC RPA1 EPB41L2	8.35e-08	638	211	18	33239621
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	MAP1B USP9X MRPS35 U2AF2 UNC45A DHX15 SARS1 TXNDC5 AP1B1 AP2B1 WDR77 UBR4 IDH2 ECPAS ACTR3 RHOB ACTR1A GTF2I CCT8 MACF1 PRKDC RPA1 CDC42 EPB41L2	1.58e-07	1149	211	24	35446349
Pubmed	Tagging genes with cassette-exchange sites.	ZNF93 USP9X CHM EZH2 TIPIN RABGAP1L DHX29 UBR4 ARHGEF12 XPO4 MACF1 ZMYM4 EPHA4	1.60e-07	335	211	13	15741177
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	PRMT8 USP9X DDN NLGN3 AP1B1 AP2B1 SHISA6 GRIA3 CNKSR2 MACF1 CDC42 EPB41L2	1.74e-07	281	211	12	28706196
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ZNF93 RAPGEF6 SETX ITPR1 NLGN3 PSME4 ALDH1L2 PGAP1 VPS35L TFB2M SLU7 FBXO11 IGF2R TBC1D31 RLIM ACIN1 MACF1 SLC35F2 EIF2AK4 RPA1 CDC42 AGRN VPS13B	2.22e-07	1084	211	23	11544199
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	MAP1B MYO5B RPS6KA2 U2AF2 PFN2 ITIH1 ITPR1 DHX15 AP1B1 AP2B1 TDRD6 KDM6A SLC25A4 SLC25A5 CCT8 EPB41L2 LGI1	2.95e-07	621	211	17	22794259
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	PALD1 MAP1B ZC3H15 USP9X UNC45A PFN2 DHX15 DHX29 SLC25A5 ARHGEF12 XPNPEP1 ECPAS IGF2R CCT8 MACF1 PRKDC RPA1 EPB41L2	3.84e-07	708	211	18	39231216
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	SCFD2 WDR64 USP9X MRPS35 TXNDC5 AP1B1 SUPT7L VPS13A KDM6A UTY IGSF3 UBR4 SLU7 KIF7 RHOB USP8 WDFY3	4.30e-07	638	211	17	31182584
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	MAP1B VPS13C ADAM7 PFN2 EZH2 DHX15 TXNDC5 AP2B1 SLC25A4 SLC25A5 LAMP1 IDH2 ACTR3 ZFPM2 RHOC CCT8 PRKDC CDC42 AGRN	5.34e-07	803	211	19	36517590
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	U2AF2 DHX15 TXNDC5 AP1B1 AP2B1 GGCT MOV10L1 SLC25A5 UBR4 XPNPEP1 IDH2 ECPAS ACTR3 RHOC ACTR1A CCT8 MACF1 PRKDC CDC42	5.75e-07	807	211	19	30575818
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MAP1B USP9X INTS1 U2AF2 DHX15 AP1B1 AP2B1 UBR4 ECPAS ACTR3 GTF2I IGF2R CTCF ACIN1 MACF1 PRKDC EPB41L2	5.92e-07	653	211	17	22586326
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	ZC3H15 USP9X MRPS35 USP9Y DHX15 TXNDC5 AP1B1 AP2B1 RABGAP1L GTF2IRD2 DHX29 WDR77 SLC25A4 SLC25A5 ACTR1A GTF2IRD2B GTF2I IGF2R CTCF CCT8 MACF1 PRKDC SPATA13	6.45e-07	1153	211	23	29845934
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SETX MAP1B U2AF2 UNC45A DHX15 FBXL18 PSME4 AP2B1 GGCT DHX29 SLC25A5 UBR4 SLU7 AMBRA1 ACTR3 ACTR1A GTF2I CCT8 ACIN1 MACF1 PRKDC WDFY3 RPA1 AGRN EPB41L2	8.27e-07	1353	211	25	29467282
Pubmed	Evolution of general transcription factors.	GTF2IRD2 GTF2IRD2B GTF2I	8.77e-07	4	211	3	23229069
Pubmed	Analysis of the human VPS13 gene family.	VPS13C VPS13A VPS13B	8.77e-07	4	211	3	15498460
Pubmed	Rac-GAP alpha-chimerin regulates motor-circuit formation as a key mediator of EphrinB3/EphA4 forward signaling.	EPHB3 CHN1 EPHA4	8.77e-07	4	211	3	17719550
Pubmed	GTF2IRD2 from the Williams-Beuren critical region encodes a mobile-element-derived fusion protein that antagonizes the action of its related family members.	GTF2IRD2 GTF2IRD2B GTF2I	8.77e-07	4	211	3	22899722
Pubmed	TFII-I gene family during tooth development: candidate genes for tooth anomalies in Williams syndrome.	GTF2IRD2 GTF2IRD2B GTF2I	8.77e-07	4	211	3	17823943
Pubmed	Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.	GTF2IRD2 GTF2IRD2B GTF2I	8.77e-07	4	211	3	21328569
Pubmed	Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility.	USP9Y KDM6A UTY	8.77e-07	4	211	3	10767340
Pubmed	Functional analysis of secreted and transmembrane proteins critical to mouse development.	LAMA1 SEMA6A CDC42 AGRN EPHA4	1.17e-06	31	211	5	11431694
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PALD1 DDN USP19 RABGAP1L ZSWIM5 ARHGEF12 ADGRL1 CNKSR2 USP8 ACIN1 MACF1 VPS13B SPATA13	1.43e-06	407	211	13	12693553
Pubmed	A protein interaction landscape of breast cancer.	MYO5B ZC3H15 USP9X EZH2 SARS1 AP2B1 GGCT COL1A2 UBR4 ECPAS IGF2R CTCF ACIN1 MACF1 RPA1 RPAP2	1.92e-06	634	211	16	34591612
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MYO5B USP9X CCDC18 EYA1 ITPR1 TXNDC5 VPS13A KDM6A COL1A2 SLC25A5 XPO4 ACTR3 KIF7 PTP4A3 VIPAS39 IGF2R TBC1D31 EIF2AK4 SCIN RPA1 SIX2	1.93e-06	1049	211	21	27880917
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	MAP1B USP9X MRPS35 PFN2 ITPR1 TXNDC5 RABGAP1L DHX29 SHISA6 IGSF3 SLC25A5 UBR4 ADGRL1 GRIA3 CNKSR2 IDH2 AQP4 VIPAS39 CCT8 MACF1 CDC42 EPB41L2	1.94e-06	1139	211	22	36417873
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	MAP1B ZC3H15 USP9X MRPS35 U2AF2 PFN2 DHX15 TXNDC5 AP1B1 AP2B1 GGCT TIPIN TFB2M WDR77 SLC25A4 SLC25A5 ACTR1A MRPL18 GTF2I CCT8 PRKDC RPA1 CDC42 RPAP2	2.24e-06	1335	211	24	29229926
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MAP1B MYO5B USP9X PFN2 DHX15 NLGN3 SARS1 AP1B1 AP2B1 DHX29 VWF SLC25A4 SLC25A5 ARHGEF12 ADGRL1 CNKSR2 IDH2 AQP4 ACTR3 ACTR1A PLXNA4 CCT8 MACF1 EPB41L2 LGI1	2.25e-06	1431	211	25	37142655
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SETX MAP1B ZC3H15 INTS1 U2AF2 USP9Y DHX15 AP2B1 CLK1 DNMT3B SLC25A4 SLC25A5 RBM45 MED16 ARRDC5 FBXO11 IDH2 ACIN1 MACF1 PRKDC AGRN	3.12e-06	1082	211	21	38697112
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	SETX STAG1 INTS1 U2AF2 UNC45A AP1B1 RBM45 ACTR1A ORC5 GNA14 CCT8 ACIN1 MACF1 PRKDC RPA1	3.14e-06	582	211	15	20467437
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	MAP1B ZC3H15 USP9X PFN2 USP19 DHX15 TXNDC5 AP1B1 GGCT DHX29 SLC25A5 UBR4 LAMP1 XPNPEP1 ECPAS ACTR3 ACTR1A IGF2R CCT8 ACIN1 VSIG8 PRKDC NGLY1 CDC42	3.35e-06	1367	211	24	32687490
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	USP9X USP19 KIF7 ACTR1A USP8 GTF2I CTCF RPA1	3.48e-06	147	211	8	29576527
Pubmed	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.	MAP1B UNC45A PFN2 SLC25A5 LAMP1 IDH2 ACTR3 ACTR1A IGF2R CCT8 PRKDC	3.68e-06	312	211	11	37120454
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	MAP1B MRPS35 UNC45A USP19 AP2B1 TIPIN SUPT7L RBM45 AMBRA1 FBXO11 CNKSR2 ICE1 KIF7 USP8 GTF2I IGF2R EIF2AK4 VSIG8 ZMYM4 RPAP2	3.74e-06	1005	211	20	19615732
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	SETX NEK6 ZC3H15 DHX15 TXNDC5 AP1B1 AP2B1 KDM6A MNDA SLC25A5 MED16 SLU7 ECPAS ACTR1A ORC5 GTF2I CCT8 PRKDC RPA1 CDC42 ZMYM4	4.20e-06	1103	211	21	34189442
Pubmed	Rho GTPases and the actin cytoskeleton.	RHOB RHOC CDC42	4.34e-06	6	211	3	9438836
Pubmed	Small GTP-binding proteins and the regulation of the actin cytoskeleton.	RHOB RHOC CDC42	4.34e-06	6	211	3	7888179
Pubmed	The bacterial virulence factor lymphostatin compromises intestinal epithelial barrier function by modulating rho GTPases.	RHOB RHOC CDC42	4.34e-06	6	211	3	19286565
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	MYO5B VPS13C PFN2 ADH6 GGCT CAPN5 MNDA VWF ARHGEF12 LAMP1 CNKSR2 ACTR3 RHOB RHOC ACTR1A IGF2R CCT8 SCIN CCDC180 CDC42	4.40e-06	1016	211	20	19056867
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ENDOD1 INTS1 DTX3L DHX15 TXNDC5 CLK1 VPS35L IGSF3 LRRC8E SLC25A5 MED16 LAMP1 FBXO11 ORC5 IGF2R FAM111A CTCF ZNF808 SARAF PRKDC CDC42 ZMYM4	4.65e-06	1203	211	22	29180619
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	RPS6KA2 TCEANC CHN1 CC2D2B RABGAP1L SEMA6A DHX29 KDM6A ARV1 POLB ARHGEF12 XPO4 FANCL EEF1AKMT1 SCIN VPS13B	5.20e-06	686	211	16	29987050
Pubmed	Charting the molecular network of the drug target Bcr-Abl.	USP9X USP9Y AP1B1 AP2B1 SLC25A5 UBR4 GTF2I CCT8 VSIG8 PRKDC	5.84e-06	266	211	10	19380743
Pubmed	Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1.	RAPGEF6 MAP1B USP9X KBTBD7 DHX15 GGCT WDR77 CCT8 ACIN1 EPB41L2	6.66e-06	270	211	10	24366813
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	SETX STAG1 MYO5B INTS1 UNC45A DHX15 WDR77 UBR4 GTF2I PRKDC	7.10e-06	272	211	10	31010829
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	STAG1 MAP1B MRPS35 U2AF2 DHX29 SLC25A4 SLC25A5 UBR4 IDH2 ACTR3 ACTR1A CCT8 PRKDC RPA1 CDC42 EPB41L2	7.19e-06	704	211	16	29955894
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	MAP1B U2AF2 DHX15 DHX29 GTF2I IGF2R CCT8 RPA1 EPB41L2	7.29e-06	215	211	9	35973513
Pubmed	Proteomic Analysis of the Spinophilin Interactome in Rodent Striatum Following Psychostimulant Sensitization.	MAP1B PFN2 ITPR1 AP1B1 AP2B1 SLC25A4 SLC25A5 ACTR3 ACTR1A CCT8 CDC42 LGI1	7.44e-06	403	211	12	30562941
Pubmed	Two murine and human homologs of mab-21, a cell fate determination gene involved in Caenorhabditis elegans neural development.	NPY2R MAB21L2 MAB21L1	7.57e-06	7	211	3	10556287
Pubmed	The mouse Y chromosome interval necessary for spermatogonial proliferation is gene dense with syntenic homology to the human AZFa region.	USP9Y UTY ZFY	7.57e-06	7	211	3	9736773
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	ZC3H15 MRPS35 U2AF2 DHX15 SARS1 TXNDC5 SLC25A4 SLC25A5 UBR4 IDH2 ECPAS ACTR1A CCT8 ACIN1 MACF1 PRKDC	8.13e-06	711	211	16	33022573
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	MRPS35 EYA1 UNC45A TXNDC5 AP1B1 AP2B1 PRMT9 DHX29 WDR77 UBR4 XPO4 AMBRA1 ECPAS KIF7 PTP4A3 GTF2I CCT8 PRKDC NGLY1	8.76e-06	974	211	19	28675297
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	U2AF2 DHX15 KDM6A ECPAS GTF2I ACIN1 PRKDC RPA1 ZMYM4	8.77e-06	220	211	9	35785414
Pubmed	PEG3 binds to H19-ICR as a transcriptional repressor.	IGF2R CTCF SLC35F2 IL1R1	8.84e-06	22	211	4	27824289
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	USP9X UNC45A USP19 DHX15 SARS1 TXNDC5 PSME4 AP1B1 AP2B1 WDR77 UBR4 LAMP1 XPNPEP1 ECPAS ACTR3 ACTR1A USP8 GTF2I CCT8 MACF1 PRKDC RPA1 CDC42 EPB41L2	9.52e-06	1455	211	24	22863883
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SETX U2AF2 UNC45A DHX15 TXNDC5 AP1B1 AP2B1 WDR77 SLC25A5 RBM45 LAMP1 FBXO11 ACTR3 RHOC FCF1 GTF2I FAM111A CTCF CCT8 ACIN1 EIF2AK4 RPA1 EPB41L2	1.13e-05	1371	211	23	36244648
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	EPHB3 MAP1B EZH2 AP2B1 SEMA6A RHOB ACIN1 MACF1 CDC42 EPHA4 RPAP2	1.34e-05	358	211	11	32460013
Pubmed	Genomic analysis of mouse retinal development.	ZNF93 ENDOD1 UNC45A BMP6 TXNDC5 CLK1 RABGAP1L MERTK RALGDS SLC25A5 PTP4A3 VIPAS39 ACIN1 PRKDC WDFY3 AGRN MAB21L1 ZMYM4 EPB41L2	1.37e-05	1006	211	19	15226823
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ENDOD1 NEK6 MAP1B VPS13C RPS6KA2 U2AF2 DNAH14 NLGN3 VPS35L SEMA6A KDM6A RECK ADGRL1 ECPAS GTF2I FAM111A TTC21B MACF1 SLC35F2 EIF2AK4 ZNF839 VPS13B ZMYM4 RPAP2	1.39e-05	1489	211	24	28611215
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	USP9X VPS13C PFN2 ITIH1 NLGN3 AP1B1 SLC25A5 ADGRL1 GRIA3 ACTR3 MACF1 CDC42	1.42e-05	430	211	12	32581705
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	MYO5B INTS1 U2AF2 DHX15 WDR77 SLC25A5 ACTR1A ORC5 GTF2I CTCF CCT8 ACIN1 PRKDC EPB41L2	1.48e-05	583	211	14	29844126
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PALD1 RAPGEF6 RPS6KA2 INTS1 PSME4 PLK3 IGSF3 LRRC8E UBR4 MYOM3 AMBRA1 ADGRL1 ICE1 ACTR1A IGF2R PRKDC WDFY3 ZNF839 AGRN SPATA13	1.49e-05	1105	211	20	35748872
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SETX ZC3H15 INTS1 MRPS35 UNC45A EZH2 SUPT7L TFB2M DHX29 WDR77 FHIP1A MED16 ARHGEF12 FBXO11 ICE1 ACTR1A ORC5 CTCF CCT8 MACF1 CDC42 AGRN ZMYM4 EPB41L2	1.52e-05	1497	211	24	31527615
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	USP9X U2AF2 DHX15 SARS1 AP1B1 AP2B1 SLC25A4 SLC25A5 UBR4 IDH2 ACTR3 ACTR1A CCT8 ACIN1 RPA1	1.53e-05	665	211	15	30457570
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	USP9X U2AF2 PFN2 DHX15 SARS1 AP2B1 SLC25A4 SLC25A5 UBR4 ACTR3 HMCN1 CCT8 MACF1 VSIG8 PRKDC RPA1 CDC42	1.76e-05	844	211	17	25963833
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	PALD1 RAPGEF6 MAP1B ZC3H15 UNC45A AP2B1 DHX29 ICE1 USP8 GTF2I CTCF CCT8 ACIN1 MACF1 PRKDC SCIN RPA1 EPB41L2	1.79e-05	934	211	18	33916271
Pubmed	UTX regulates mesoderm differentiation of embryonic stem cells independent of H3K27 demethylase activity.	EZH2 KDM6A UTY	1.80e-05	9	211	3	22949634
Pubmed	Distinct roles of Rac1/Cdc42 and Rho/Rock for axon outgrowth and nucleokinesis of precerebellar neurons toward netrin 1.	RHOB RHOC CDC42	1.80e-05	9	211	3	15151987
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	ZC3H15 USP9X MRPS35 U2AF2 UNC45A PFN2 DHX15 SARS1 TXNDC5 AP1B1 AP2B1 GGCT TFB2M SLC25A4 SLC25A5 UBR4 USP8 GTF2I CCT8 MACF1 PRKDC EPB41L2 RPAP2	1.86e-05	1415	211	23	28515276
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	PALD1 ENDOD1 MYO5B MRPS35 PFN2 TXNDC5 AP2B1 RABGAP1L TFB2M SLC25A4 XPO4 AMBRA1 FANCL IDH2 ACTR3 KIF7 ACTR1A USP8 GTF2I TTC21B VSIG8 RPA1	1.98e-05	1321	211	22	27173435
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	USP9X U2AF2 USP9Y DHX15 SLC25A5 RBM45 GTF2I ACIN1 ZMYM4	2.00e-05	244	211	9	29884807
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	ZNF93 UNC45A DHX15 SARS1 AP1B1 AP2B1 COL1A2 LRRC8E LAMP1 GTF2I CCT8 RPA1	2.27e-05	451	211	12	36168627
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	UNC45A SARS1 VPS13A TFB2M WDR77 SLC25A4 AMBRA1 IDH2 ACTR3 KIF7 RHOC ACTR1A ORC5 RLIM	2.27e-05	606	211	14	36538041
Pubmed	DELTEX2 C-terminal domain recognizes and recruits ADP-ribosylated proteins for ubiquitination.	DTX3L UNC45A RPA1 EPB41L2	2.40e-05	28	211	4	32937373
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	SCFD2 PALD1 MAP1B MRPS35 UNC45A ITPR1 DHX15 AP2B1 VPS35L DHX29 WDR77 UBR4 XPO4 IDH2 MAB21L2 ECPAS ACTR3 ACTR1A MRPL18 GTF2I CCT8 PRKDC RPA1	2.45e-05	1440	211	23	30833792
Pubmed	STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production.	MAP1B ZC3H15 U2AF2 DHX15 AP1B1 DTHD1 WDR77 SLC25A5 CCT8 RPA1	2.59e-05	316	211	10	31665637
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	USP9X UNC45A AP1B1 AP2B1 UBR4 AMBRA1 IDH2 ACTR3 ACTR1A GTF2I PRKDC RPA1 EPB41L2	2.61e-05	534	211	13	35032548
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	MAP1B MRPS35 U2AF2 DHX15 CLK1 WDR77 SLC25A4 SLC25A5 SLU7 ACTR3 ACTR1A CCT8 PRKDC RPA1 CDC42	3.46e-05	714	211	15	28302793
Pubmed	Digging Deeper into CYP3A Testosterone Metabolism: Kinetic, Regioselectivity, and Stereoselectivity Differences between CYP3A4/5 and CYP3A7.	CYP3A7 CYP3A4	3.66e-05	2	211	2	28986474
Pubmed	UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition.	EZH2 KDM6A	3.66e-05	2	211	2	29045832
Pubmed	A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variants.	SCIN CDC42	3.66e-05	2	211	2	27347659
Pubmed	CTCF physically links cohesin to chromatin.	STAG1 CTCF	3.66e-05	2	211	2	18550811
Pubmed	Endothelial RhoB and RhoC are dispensable for leukocyte diapedesis and for maintaining vascular integrity during diapedesis.	RHOB RHOC	3.66e-05	2	211	2	28960175
Pubmed	Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6p.	BMP6 TXNDC5	3.66e-05	2	211	2	19694819
Pubmed	Agrin defines polarized distribution of orthogonal arrays of particles in astrocytes.	AQP4 AGRN	3.66e-05	2	211	2	19449033
Pubmed	[Semaphorin/plexin signal regulates lamina-restricted projection of hippocampal mossy fiber].	SEMA6A PLXNA4	3.66e-05	2	211	2	21089322
Pubmed	Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome.	USP9X USP9Y	3.66e-05	2	211	2	12895410
Pubmed	CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells.	STAG1 CTCF	3.66e-05	2	211	2	27219007
Pubmed	Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors.	CYP3A7 CYP3A4	3.66e-05	2	211	2	25689036
Pubmed	Immunohistochemical markers of CYP3A4 and CYP3A7: a new tool towards personalized pharmacotherapy of hepatocellular carcinoma.	CYP3A7 CYP3A4	3.66e-05	2	211	2	27349315
Pubmed	The Arp2/3 complex mediates actin polymerization induced by the small GTP-binding protein Cdc42.	ACTR3 CDC42	3.66e-05	2	211	2	9860974
Pubmed	Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer.	SEMA6A PLXNA4	3.66e-05	2	211	2	34815265
Pubmed	The Male Abnormal Gene Family 21 (Mab21) Members Regulate Eye Development.	MAB21L2 MAB21L1	3.66e-05	2	211	2	27558071
Pubmed	A novel ras-related gene family.	RHOB RHOC	3.66e-05	2	211	2	3888408
Pubmed	Sex-specific differences in expression of histone demethylases Utx and Uty in mouse brain and neurons.	KDM6A UTY	3.66e-05	2	211	2	18434530
Pubmed	Usp9y (ubiquitin-specific protease 9 gene on the Y) is associated with a functional promoter and encodes an intact open reading frame homologous to Usp9x that is under selective constraint.	USP9X USP9Y	3.66e-05	2	211	2	12925892
Pubmed	Positive and negative selection on mammalian Y chromosomes.	KDM6A UTY	3.66e-05	2	211	2	15758204
Interaction	EED interactions	SETX STAG1 MAP1B MYO5B USP9X VPS13C LAMA1 INTS1 U2AF2 UNC45A EZH2 DHX15 TXNDC5 AP2B1 VPS35L DNMT3B SLC25A4 SLC25A5 UBR4 XPO4 FBXO11 XPNPEP1 ACTR3 RHOC FCF1 ACTR1A GTF2I IGF2R TBC1D31 CTCF TTC21B CCT8 ACIN1 MACF1 PRKDC RPA1 AGRN	1.65e-07	1445	205	37	int:EED
Interaction	RICTOR interactions	MAP1B USP9X RPS6KA2 U2AF2 UNC45A PFN2 EZH2 DHX15 DHX29 SLC25A5 LAMP1 IDH2 ACTR3 RHOB RHOC ACTR1A GTF2I IGF2R CCT8 PRKDC RPA1 CDC42 EPB41L2	3.12e-06	759	205	23	int:RICTOR
Interaction	PSMD13 interactions	MAP1B U2AF2 UNC45A PFN2 EZH2 DHX15 PSME4 VPS35L UBR4 ARHGEF12 AMBRA1 ECPAS CCT8 RPA1	3.23e-06	306	205	14	int:PSMD13
Interaction	RNF123 interactions	SETX DOCK11 VPS13C LAMA1 INTS1 CHN1 DNAH14 USP19 SARS1 DEFB121 VPS13A COL1A2 MRM2 SLC25A5 UBR4 MYOM3 ICE1 ECPAS PLXNA4 CCT8 EEF1AKMT1 PRKDC RPA1 EPB41L2	3.70e-06	824	205	24	int:RNF123
Interaction	PSMA4 interactions	MAP1B USP9X U2AF2 PFN2 EZH2 DHX15 TXNDC5 PSME4 MNDA AMBRA1 ECPAS GTF2I CCT8 RPA1	3.76e-06	310	205	14	int:PSMA4
Interaction	HTT interactions	MAP1B MYO5B USP9X RPS6KA2 U2AF2 PFN2 EZH2 ITIH1 ITPR1 DHX15 PSME4 AP1B1 AP2B1 TDRD6 KDM6A WDR77 NPY2R SLC25A4 SLC25A5 ACTR3 RHOC USP8 CCT8 RPA1 EPB41L2 LGI1	4.29e-06	949	205	26	int:HTT
Interaction	TRMT61A interactions	PRMT8 AP1B1 PLK3 ARHGEF12 IDH2 RLIM SCIN RPA1	4.48e-06	92	205	8	int:TRMT61A
Interaction	RAB32 interactions	VPS13C CHM EZH2 RHOB RHOC RPA1 CDC42	5.83e-06	68	205	7	int:RAB32
Interaction	GTF2I interactions	USP9X PFN2 EZH2 AP1B1 AP2B1 GTF2IRD2 RBM45 SLU7 MAB21L2 GTF2IRD2B PTP4A3 GTF2I RLIM PRKDC RPA1	6.88e-06	373	205	15	int:GTF2I
Interaction	IL13RA2 interactions	PALD1 ENDOD1 NEK6 INTS1 ARV1 SLC25A5 ECPAS ORC5 PRKDC	1.07e-05	136	205	9	int:IL13RA2
Interaction	SLC1A5 interactions	NEK6 MAP1B RPS6KA2 MRPS35 USP19 LAMP1 ECPAS RHOB RHOC RPA1 CDC42 EPHA4	1.11e-05	252	205	12	int:SLC1A5
Interaction	TGFBR1 interactions	NEK6 CHN1 USP19 NLGN3 AP2B1 LAMP1 FANCL TMEM9B RHOB RHOC EIF2AK4 CDC42	1.40e-05	258	205	12	int:TGFBR1
Interaction	PLCB4 interactions	ITPR1 NLGN3 RHOB RHOC CDC42	1.67e-05	32	205	5	int:PLCB4
Interaction	ARHGAP1 interactions	SETX U2AF2 ITPR1 AP1B1 LAMP1 RHOB RHOC SARAF RPA1 CDC42 EPB41L2	2.80e-05	233	205	11	int:ARHGAP1
Interaction	CNTNAP2 interactions	MAP1B ITPR1 DHX29 IGSF3 ADGRL1 AQP4 CCT8 MACF1 EPB41L2	3.55e-05	158	205	9	int:CNTNAP2
Interaction	MYO1E interactions	MAP1B U2AF2 UNC45A MAB21L2 RHOB RHOC PTP4A3 RLIM RPA1 CDC42	4.36e-05	202	205	10	int:MYO1E
Interaction	CAVIN1 interactions	MAP1B EZH2 KBTBD7 RABGAP1L SEMA6A LAMP1 MAB21L2 RHOB RHOC ACIN1 CDC42 EPB41L2	4.72e-05	292	205	12	int:CAVIN1
Interaction	SLC2A1 interactions	INTS1 EZH2 TFB2M SLC25A4 ARRDC5 LAMP1 ECPAS RHOB RHOC RPA1 CDC42	4.77e-05	247	205	11	int:SLC2A1
Interaction	SHANK3 interactions	MAP1B MYO5B RPS6KA2 PFN2 ITIH1 ITPR1 SLC25A5 ADGRL1 CNKSR2 AQP4 KIF7 USP8 IGF2R CCT8 MACF1 SPATA13	5.10e-05	496	205	16	int:SHANK3
Interaction	RAB5B interactions	CHM EZH2 RHOB RHOC FCF1 SARAF RPA1 CDC42	5.32e-05	129	205	8	int:RAB5B
Interaction	SH3D19 interactions	AP2B1 ARHGEF12 ACTR3 RHOB RPA1 CDC42	7.24e-05	69	205	6	int:SH3D19
Interaction	GYPA interactions	SCFD2 SETX NEK6 RABGAP1L PRMT9 XPO4 IDH2 ECPAS ORC5	7.52e-05	174	205	9	int:GYPA
Interaction	KCNA3 interactions	PALD1 MAP1B ZC3H15 USP9X LAMA1 UNC45A PFN2 DHX15 VPS13A DHX29 SLC25A5 ARHGEF12 XPNPEP1 ECPAS PTP4A3 IGF2R CCT8 MACF1 EIF2AK4 PRKDC RPA1 EPB41L2	8.27e-05	871	205	22	int:KCNA3
Interaction	FAT1 interactions	RPS6KA2 EZH2 CLK1 SUSD4 RHOB RHOC CDC42	8.83e-05	103	205	7	int:FAT1
Interaction	ITGA1 interactions	LAMA1 RHOB RHOC PTP4A3 CDC42	1.01e-04	46	205	5	int:ITGA1
Interaction	USP9X interactions	NEK6 MAP1B USP9X RPS6KA2 USP9Y MERTK RBM45 UBR4 AMBRA1 ECPAS RHOB GTF2I RPA1 CDC42	1.13e-04	422	205	14	int:USP9X
Interaction	RAP1B interactions	MRPS35 EZH2 RGL1 RALGDS UBR4 RHOB RHOC RPA1 CDC42	1.20e-04	185	205	9	int:RAP1B
Interaction	FCHO2 interactions	AP1B1 AP2B1 LAMP1 MAB21L2 RHOB CDC42 EPHA4	1.26e-04	109	205	7	int:FCHO2
Interaction	AP2M1 interactions	RPS6KA2 EZH2 KBTBD7 AP1B1 AP2B1 SLC25A4 SLC25A5 LAMP1 MAB21L2 AQP4 RHOB RHOC PRKDC RPA1	1.37e-04	430	205	14	int:AP2M1
Interaction	BLTP1 interactions	KIF7 RHOB RHOC CDC42 VPS13B	1.37e-04	49	205	5	int:BLTP1
Interaction	TNIK interactions	DOCK11 USP9X KBTBD7 AP2B1 LAMP1 GRIA3 CNKSR2 KIF7 RHOB ACTR1A MACF1 RPA1 AGRN	1.51e-04	381	205	13	int:TNIK
Interaction	ZNF252P-AS1 interactions	VPS13C FBXO11 RLIM VPS13B	1.52e-04	27	205	4	int:ZNF252P-AS1
Interaction	CD80 interactions	INTS1 TFB2M SLC25A5 IDH2 ORC5 PRKDC	1.54e-04	79	205	6	int:CD80
Interaction	FLOT2 interactions	RPS6KA2 U2AF2 EZH2 ARRDC5 LAMP1 ECPAS RHOB RHOC RPA1 CDC42 EPHA4	1.70e-04	285	205	11	int:FLOT2
Interaction	HLA-B interactions	INTS1 EZH2 TFB2M SLC25A4 ECPAS RHOB RHOC PRKDC WDFY3 CDC42	1.75e-04	239	205	10	int:HLA-B
Interaction	CIB2 interactions	SETX MED16 RLIM EIF2AK4 VPS13B EPHA4	1.77e-04	81	205	6	int:CIB2
Interaction	WARS1 interactions	U2AF2 EZH2 SARS1 TXNDC5 DNMT3B XPNPEP1 GTF2I CCT8 RPA1	1.93e-04	197	205	9	int:WARS1
Interaction	FLRT2 interactions	ADGRL1 RHOB RHOC CDC42	2.02e-04	29	205	4	int:FLRT2
Interaction	OLR1 interactions	EZH2 RHOB RHOC CDC42	2.02e-04	29	205	4	int:OLR1
Interaction	TUBB4B interactions	SETX MAP1B USP9X U2AF2 EZH2 SLC25A4 UBR4 ECPAS ACTR1A RLIM CCT8 RPA1 CDC42 ZMYM4 EPB41L2 EPHA4	2.07e-04	560	205	16	int:TUBB4B
Interaction	AP2A2 interactions	NLGN3 AP1B1 AP2B1 LAMP1 MAB21L2 RLIM RPA1 CDC42 AGRN	2.08e-04	199	205	9	int:AP2A2
Interaction	SBF1 interactions	RPS6KA2 COL1A2 LAMP1 RHOB RHOC ACIN1 RPA1 CDC42	2.09e-04	157	205	8	int:SBF1
Interaction	TENM2 interactions	LAMP1 RHOB RHOC	2.13e-04	12	205	3	int:TENM2
Interaction	GTF2IRD2 interactions	GTF2IRD2 GTF2IRD2B GTF2I	2.13e-04	12	205	3	int:GTF2IRD2
Interaction	PPP6R2 interactions	MYO5B RPS6KA2 EZH2 AP1B1 AP2B1 PRKDC RPA1	2.18e-04	119	205	7	int:PPP6R2
Interaction	SIRT7 interactions	MAP1B USP9X INTS1 U2AF2 KBTBD7 DHX15 AP1B1 AP2B1 WDR77 UBR4 ECPAS ACTR3 GTF2I IGF2R CTCF ACIN1 MACF1 PRKDC EPB41L2	2.24e-04	744	205	19	int:SIRT7
Interaction	NCAPG interactions	PRMT8 U2AF2 DTX3L DNMT3B POLB ACTR1A PTP4A3 CTCF RPA1	2.33e-04	202	205	9	int:NCAPG
Interaction	PFN1 interactions	RAPGEF6 VPS13C EYA1 PFN2 EZH2 RABGAP1L ARHGEF12 KIF7 RHOB RHOC MACF1 SCIN RPA1 ZMYM4 RPAP2	2.35e-04	509	205	15	int:PFN1
Interaction	ITGB1 interactions	RPS6KA2 LAMA1 EZH2 UBR4 LAMP1 RHOB RHOC USP8 RLIM EIF2AK4 PRKDC RPA1 CDC42	2.42e-04	400	205	13	int:ITGB1
Interaction	STIP1 interactions	USP9X U2AF2 UNC45A EZH2 USP19 DHX15 SARS1 TXNDC5 AP1B1 AP2B1 CLK1 CAPN5 WDR77 SLC25A5 UBR4 AMBRA1 ECPAS ACTR1A GTF2I CCT8 PRKDC RPA1 EPB41L2	2.46e-04	1006	205	23	int:STIP1
Interaction	C19orf38 interactions	SETX RABGAP1L PRMT9 XPO4 ORC5 PRKDC	2.46e-04	86	205	6	int:C19orf38
Interaction	ARL8B interactions	EZH2 USP19 LAMP1 RHOB RHOC IGF2R SARAF RPA1 CDC42	2.50e-04	204	205	9	int:ARL8B
Interaction	MACROH2A1 interactions	MAP1B USP9X EZH2 MERTK WDR77 DNMT3B RHOB RHOC GTF2I CTCF RLIM SARAF RPA1 CDC42	2.63e-04	458	205	14	int:MACROH2A1
Interaction	DOCK11 interactions	DOCK11 UBR4 ECPAS RHOB CDC42	2.83e-04	57	205	5	int:DOCK11
GeneFamily	Rho family GTPases	RHOB RHOC CDC42	4.70e-04	20	140	3	390
GeneFamily	Ubiquitin specific peptidases	USP9X USP9Y USP19 USP8	9.26e-04	56	140	4	366
GeneFamily	Ubiquitin protein ligase E3 component n-recognins	UBR4 FBXO11	1.22e-03	7	140	2	785
GeneFamily	Fibronectin type III domain containing	EPHB3 MERTK CNTN4 IL31RA MYOM3 EPHA4	1.55e-03	160	140	6	555
GeneFamily	Cytochrome P450 family 3	CYP3A7 CYP3A4	1.62e-03	8	140	2	1002
GeneFamily	Protein arginine methyltransferases	PRMT8 PRMT9	2.07e-03	9	140	2	691
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SETX STAG1 MAP1B USP9X RPS6KA2 ITPR1 DHX15 RGL1 PSME4 RABGAP1L VPS13A COL1A2 ORC5 IGF2R TBC1D31 CTCF MACF1 WDFY3 IL1R1 VPS13B ZMYM4 EPHA4	1.10e-06	856	205	22	M4500
Coexpression	HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS	LAMA1 FREM1 HMCN1 AGRN LGI1	1.60e-06	26	205	5	M47999
Coexpression	SHEN_SMARCA2_TARGETS_UP	SETX STAG1 ZC3H15 USP9X VPS13C USP9Y DHX29 FBXO11 ECPAS ACTR3 CTCF MACF1 WDFY3 RPA1	7.95e-06	429	205	14	M29
Coexpression	FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP	MYO5B USP9X MRPS35 TCEANC CHM CHN1 ITPR1 FCGR2B RABGAP1L CCR6 KDM6A FHIP1A SLC25A4 GRIA3 ICE1 SARAF	1.69e-05	587	205	16	M40869
Coexpression	GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	ZC3H15 EZH2 CLK1 PGAP1 USP8 GTF2I TTC21B SARAF NGLY1	2.87e-05	199	205	9	M3186
Coexpression	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP	EPHB3 RPS6KA2 ITPR1 RGL1 IDH2 GNA14 EIF2AK4 PRKDC IL1R1	2.98e-05	200	205	9	M7251
Coexpression	GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN	CYP3A7 SETX STAG1 PFN2 SUPT7L RECK IGSF3 RALGDS IGF2R	2.98e-05	200	205	9	M2917
Coexpression	RUNNE_GENDER_EFFECT_UP	USP9Y UTY ZFY	3.83e-05	9	205	3	M17072
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	NEK6 LAMA1 FREM1 RECK COL1A2 GRIA3 GNA14 HMCN1 IL1R1	3.03e-06	125	201	9	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000
CoexpressionAtlas	dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000	MAP1B EYA1 CHN1 ALDH1L2 PGAP1 RNF32 NPY2R CNKSR2 MAB21L2 MAB21L1 LGI1	3.74e-06	202	201	11	gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	ZNF717 ENDOD1 SETX MAP1B USP9X DTX3L EYA1 NLGN3 VPS13A IGSF3 RNF32 CRISPLD2 ECPAS GNA14 HMCN1 AGRN SIX2 MAB21L1 VPS13B ZMYM4 EPHA4	2.79e-05	806	201	21	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP9Y CLK1 PGAP1 VPS13A DTHD1 UTY PARP15 SLFN13 MACF1 VPS13B	3.43e-08	199	207	10	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB3 RPS6KA2 DTHD1 FHIP1A NPY2R SLC25A5 ZFPM2 PLXNA4 CCDC180	2.22e-07	185	207	9	05bc89a566b0db90ae06506e067190a4739a0974
ToppCell	Control-Neu_1\|World / 5 Neutrophil clusters in COVID-19 patients	PFN2 ALDH1L2 ARRDC5 RUBCNL ICE1 PLXNA4 SARAF GRAMD1C	2.79e-07	138	207	8	b7920c9a28d28220e7e4b30cd91ba13d0548eb76
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	LAMA1 FREM1 COL1A2 CRISPLD2 CNTN4 PLXNA4 MACF1 IL1R1 EPB41L2	4.28e-07	200	207	9	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WDR64 LAMA1 FREM1 MOV10L1 TDRD6 DTHD1 CNTN4 HMCN1	8.60e-07	160	207	8	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WDR64 LAMA1 FREM1 MOV10L1 TDRD6 DTHD1 CNTN4 HMCN1	8.60e-07	160	207	8	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	CD8+_Memory_T_cell-FLU-3\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	SCFD2 PFN2 CCR6 ZSWIM5 ECPAS ZNF839 CCDC180 GRAMD1C	1.48e-06	172	207	8	45ac433dbb3796f69e886c04457b2971403050ee
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRMT8 LAMA1 DNAH14 FREM1 BMP6 SHISA6 SUSD4 IDH2	1.69e-06	175	207	8	e5467dacf81f1f913b1719931cf1a7331434a7e7
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACR CHN1 CC2D2B BMP6 VWF ZFPM2 GNA14 IL1R1	2.08e-06	180	207	8	27e8bbee388e64dd79d70b160b76d45b1f398006
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C PGAP1 KDM6A MNDA CRIP1 RHOB USP8 MACF1	2.26e-06	182	207	8	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PALD1 ITIH1 CC2D2B FCGR2B CCR6 IGSF3 SLC35F2 IL1R1	2.45e-06	184	207	8	0a26bcc6610f756939e32a4d6dfeebcbf3a1db86
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	DOCK11 FREM1 RGL1 ALDH1L2 RECK CNTN4 HMCN1 EPB41L2	2.45e-06	184	207	8	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PALD1 ITIH1 CC2D2B FCGR2B CCR6 IGSF3 SLC35F2 IL1R1	2.55e-06	185	207	8	fec16a5e527fdef32d25957451b6e8ee9796cafd
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CHN1 CC2D2B BMP6 SEMA6A VWF ZFPM2 GNA14 IL1R1	2.76e-06	187	207	8	e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCell	COVID-19-Heart-EC_(POSTN)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CHN1 BMP6 VWF GNA14 HMCN1 PLXNA4 IL1R1 EPHA4	2.99e-06	189	207	8	7346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PGAP1 SEMA6A COL1A2 CRISPLD2 RARRES1 GNA14 IL1R1 EPB41L2	3.11e-06	190	207	8	0fea33f2dc1efa23aaa2da1c318482a52a313ff1
ToppCell	facs-Skin-Anagen-3m\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	U2AF2 BMP6 UTY RALGDS LAMP1 ACTR3 ACTR1A CDC42	3.11e-06	190	207	8	3466cebab16964e94da130d0673fa32e7d90b5ed
ToppCell	droplet-Marrow-nan-24m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TXNDC5 MNDA SLC25A4 LAMP1 GRIA3 IDH2 CRIP1 EEF1AKMT1	3.11e-06	190	207	8	e2fdbfaf08da3274b6bdda615386aa880040a90a
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	CHN1 BMP6 MOV10L1 VWF GNA14 HMCN1 PLXNA4 IL1R1	3.36e-06	192	207	8	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS6KA2 EYA1 FREM1 BMP6 IGSF3 VWF IGF2R HMCN1	3.36e-06	192	207	8	14a816ef116aa992f86edab411f043cf7d07fe04
ToppCell	facs-Heart-LA-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS6KA2 EYA1 FREM1 BMP6 IGSF3 VWF IGF2R HMCN1	3.36e-06	192	207	8	847822514d747a21d5eb40e04ba9a023fd32bd65
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BMP6 SEMA6A SUSD4 VWF ARHGEF12 ZFPM2 HMCN1 MACF1	3.63e-06	194	207	8	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B USP9X VPS13C RPS6KA2 CLK1 VPS13A UTY MACF1	3.77e-06	195	207	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B USP9X VPS13C RPS6KA2 CLK1 VPS13A UTY MACF1	3.77e-06	195	207	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CHN1 CC2D2B BMP6 SEMA6A VWF ZFPM2 GNA14 IL1R1	4.06e-06	197	207	8	b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576
ToppCell	COVID-19-kidney-Fibroblast-2\|kidney / Disease (COVID-19 only), tissue and cell type	MAP1B COL1A2 CRISPLD2 RARRES1 ZFPM2 GNA14 IL1R1 EPB41L2	4.22e-06	198	207	8	ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	LAMA1 FREM1 COL1A2 CRISPLD2 CNTN4 PLXNA4 MACF1 SPATA13	4.38e-06	199	207	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CYP3A4 RGL1 AQP4 GNA14 CHST4 MACF1 GRAMD1C LGI1	4.54e-06	200	207	8	07d942803360e1a1e8e131d6e31c726dd0db1a0b
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	RPS6KA2 LAMA1 EYA1 MERTK AQP4 GNA14 GRAMD1C LGI1	4.54e-06	200	207	8	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	SETX DTX3L USP9Y DTHD1 ARHGEF12 IGF2R SLFN13 MACF1	4.54e-06	200	207	8	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	EPHB3 PALD1 FCGR2B CCR6 ADGRL1 IL1R1 SLC16A8	4.86e-06	143	207	7	5a279da1cd8e63db32f7c85a73b493c2121d0a96
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	EPHB3 PALD1 FCGR2B CCR6 ADGRL1 IL1R1 SLC16A8	5.32e-06	145	207	7	997bd540c43725a85ca97e4b79ebe0d336860287
ToppCell	facs-Large_Intestine-Distal-24m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	H1-9P ALDH1L2 CAPN5 DTHD1 CRIP1 RHOC SCIN	6.09e-06	148	207	7	941bad657064b3d37cae8b66df99c1aa1098c088
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	EPHB3 DNAH14 PGAP1 CCR6 MERTK ZNF674 GNA14	7.25e-06	152	207	7	ca23261d8ef263cc697b8d7e7cb2afec8bc564f2
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	EPHB3 DNAH14 PGAP1 CCR6 MERTK ZNF674 GNA14	1.01e-05	160	207	7	19105debef96ea0c267d6a1d332303ec668ae47e
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCGR2B PGAP1 CCR6 TFB2M RUBCNL ECPAS VIPAS39	1.10e-05	162	207	7	e81dec1db8e5a808d96e58410c91961e5d065c94
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	RAPGEF6 USP9Y ITPR1 CLK1 KDM6A UTY MACF1	1.10e-05	162	207	7	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCGR2B PGAP1 CCR6 TFB2M RUBCNL ECPAS VIPAS39	1.10e-05	162	207	7	d19b469f64c9064cfb82dadb6c8135e28949a02a
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCGR2B PGAP1 CCR6 TFB2M RUBCNL ECPAS VIPAS39	1.10e-05	162	207	7	10c2aa047f33f48e4abe676236bbdb593079dd1d
ToppCell	droplet-Lung-LUNG-1m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEK6 EZH2 TIPIN GPR33 XPO4 SCIN GRAMD1C	1.34e-05	167	207	7	e30e7ac8ea4399dc3c1d94fc6b857afc80a7a671
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3\|TCGA-Stomach / Sample_Type by Project: Shred V9	FCGR2B DTHD1 PARP15 CNTN4 ARRDC5 FCGR2C HMCN1	1.34e-05	167	207	7	d2230c894ccf9dbba9196e079ae81f384d43da63
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CHN1 CC2D2B SEMA6A VWF ZFPM2 GNA14 IL1R1	1.34e-05	167	207	7	d7fe24cdc4b55a9555ce9e20699f5036b88148e9
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRMT8 MAP1B PGAP1 GNA14 SLFN13 GRAMD1C SLC16A8	1.45e-05	169	207	7	8bca402e144819cb9a8d431d6bf9429be2fff6d6
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th\|T/NK_cells / Location, Cell class and cell subclass	MYO5B CHM PGAP1 KDM6A MNDA EIF2AK4 WDFY3	1.68e-05	173	207	7	42c911ed16fabdabef063830e8407192d8bde950
ToppCell	nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PALD1 RABGAP1L FHIP1A POLB RUBCNL PLXNA4 EIF2AK4	1.81e-05	175	207	7	37c2d4e0b6e9a3171931797ce9a54f3347288e57
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ITIH1 FREM1 IL31RA MAB21L2 MAB21L1	1.86e-05	70	207	5	677deb7c7c100756a4cdc788d61feb45039a9a97
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DTX3L DNMT3B IL31RA GRIA3 IDH2 TBC1D31 SCIN	1.88e-05	176	207	7	d43d9e86c4d4fa1e88fbf2b899ac7143717aac90
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B COL1A2 CRISPLD2 GPR33 ZFPM2 GNA14 EPB41L2	2.02e-05	178	207	7	d4ecb84e9b1f4ec49c519321156aa10f9bd34cce
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CEP104 FBXL18 FCGR2B RECK PARP15 RARRES1 RHOC	2.10e-05	179	207	7	5be883d7d0be3180bb9844e4a757f0dd247294e4
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-5\|TCGA-Breast / Sample_Type by Project: Shred V9	CHN1 AP1B1 GGCT DNMT3B SLC25A5 IDH2 ACTR3	2.33e-05	182	207	7	9e48d5b634603bc7a8d29290202a311457678328
ToppCell	droplet-Marrow-nan-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C TXNDC5 MNDA SLC25A4 GRIA3 CRIP1 USP8	2.33e-05	182	207	7	bc8d621be57f76d718d9b0f11e023b0f4dcb668d
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PALD1 CHN1 TIPIN SLC25A5 IGF2R FAM111A CCT8	2.42e-05	183	207	7	523896bd1a93bdda81a009768baa3a1bdbd108b8
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETX VPS13C KDM6A CRIP1 RHOB USP8 MACF1	2.50e-05	184	207	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	Control-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	CEP104 VPS13A XPNPEP1 ECPAS IL1R1 EPB41L2 RPAP2	2.50e-05	184	207	7	ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C KDM6A MNDA CRIP1 RHOB USP8 MACF1	2.59e-05	185	207	7	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	SETX STAG1 ARHGEF12 USP8 HMCN1 CTCF VPS13B	2.68e-05	186	207	7	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	COPD-Stromal-Pericyte\|Stromal / Disease state, Lineage and Cell class	PALD1 MAP1B RPS6KA2 CHN1 MERTK CNTN4 PTP4A3	2.77e-05	187	207	7	406ecd1dabb3ed8d871aef159f7bd1e383434953
ToppCell	COVID-19-lung-Vein_EC\|lung / Disease (COVID-19 only), tissue and cell type	CHN1 CC2D2B SEMA6A VWF ZFPM2 GNA14 IL1R1	2.87e-05	188	207	7	d582b76fc2faac526c9bf97503041129e1a6a211
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	CHN1 COL1A2 CRISPLD2 RARRES1 ZFPM2 PLXNA4 IL1R1	2.97e-05	189	207	7	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	STAG1 LAMA1 FREM1 BMP6 UTY AMBRA1 WDFY3	2.97e-05	189	207	7	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	facs-Skin-Anagen\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	U2AF2 BMP6 UTY RALGDS LAMP1 ACTR3 ACTR1A	2.97e-05	189	207	7	adbfc723130079b4caf551f66d2aee86fab1903c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITPR1 RGL1 COL1A2 CRISPLD2 CNTN4 GNA14 EPB41L2	2.97e-05	189	207	7	c734e5693808a0333139e87bd5be2597a9252afe
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITPR1 RGL1 COL1A2 CRISPLD2 CNTN4 GNA14 EPB41L2	3.07e-05	190	207	7	2e592323085ba9c019d678ac2a784462ab470ed9
ToppCell	facs-Skin-Anagen-3m-Epithelial\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	U2AF2 BMP6 UTY RALGDS LAMP1 ACTR3 ACTR1A	3.07e-05	190	207	7	888ded899f0513d41bf655896d59ae8ef74e0978
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITPR1 RGL1 COL1A2 CRISPLD2 CNTN4 GNA14 EPB41L2	3.07e-05	190	207	7	445952b70abffadb6ccc1ed4bbf61a88b06b73b3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITPR1 RGL1 COL1A2 CRISPLD2 CNTN4 GNA14 EPB41L2	3.18e-05	191	207	7	c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell	368C-Myeloid-Dendritic-cDC2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	PALD1 FCGR2B CCR6 IDH2 RHOC EIF2AK4 IL1R1	3.18e-05	191	207	7	85dba3a8a52307df52d1d78a6f278501298f3067
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FREM1 PGAP1 COL1A2 CRISPLD2 ZFPM2 HMCN1 MACF1	3.18e-05	191	207	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITPR1 RGL1 COL1A2 CRISPLD2 CNTN4 GNA14 EPB41L2	3.18e-05	191	207	7	cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL1A2 CRISPLD2 RARRES1 CNKSR2 ZFPM2 GNA14 EPB41L2	3.28e-05	192	207	7	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Vein\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHN1 PGAP1 SEMA6A VWF ZFPM2 GNA14 HMCN1	3.28e-05	192	207	7	81baf1c4063469bb0c03a8602b40e387ba7b0dfb
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FREM1 PGAP1 COL1A2 CRISPLD2 ZFPM2 HMCN1 MACF1	3.28e-05	192	207	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B COL1A2 CRISPLD2 RARRES1 CNKSR2 ZFPM2 EPB41L2	3.39e-05	193	207	7	09a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHN1 BMP6 SEMA6A MERTK SUSD4 VWF ZFPM2	3.39e-05	193	207	7	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	MAP1B CHN1 COL1A2 CRISPLD2 ZFPM2 HMCN1 IL1R1	3.39e-05	193	207	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	facs-Liver-Non-hepatocytes-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGL1 FCGR2B SEMA6A MERTK RHOB MACF1 EPB41L2	3.39e-05	193	207	7	8084fa0ce61f1f4a728423b6b81df04eaa5af5b6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CHN1 CC2D2B BMP6 VWF GNA14 PLXNA4 EPHA4	3.39e-05	193	207	7	0b328f725f6feba263783eaca60c142e80df90f3
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHN1 PGAP1 SEMA6A VWF ZFPM2 GNA14 HMCN1	3.39e-05	193	207	7	7261c1ce30c796b61c6ec58e64a051baa24732ff
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	WDR64 CYP3A4 BMP6 TXNDC5 ALDH1L2 MERTK SLC35F2	3.39e-05	193	207	7	5c5543e7c83ecea44d23521246592c0301044173
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	USP9X USP8 IGF2R PRKDC WDFY3 VPS13B ZMYM4	3.39e-05	193	207	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VPS13C ITPR1 AP1B1 FCGR2B PARP15 RUBCNL RHOB	3.51e-05	194	207	7	ff661419b697aef51a53fdeac8d37d870d65f491
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACR CHN1 BMP6 SEMA6A VWF GNA14 EPB41L2	3.51e-05	194	207	7	68004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SCFD2 CHN1 FREM1 RARRES1 SLFN13 MACF1 IL1R1	3.51e-05	194	207	7	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGL1 BMP6 FCGR2B SEMA6A RHOB RHOC HMCN1	3.62e-05	195	207	7	12ba6d95e42d06b1991b011043c0e3370a7b4131
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAP1B COL1A2 CRISPLD2 ZFPM2 GNA14 IL1R1 EPB41L2	3.62e-05	195	207	7	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	MAP1B DOCK11 IGSF3 COL1A2 CRISPLD2 CNKSR2 LGI1	3.74e-05	196	207	7	24d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PFN2 CHN1 MOV10L1 CAPN5 COL1A2 ZSWIM5 KIF7	3.74e-05	196	207	7	614a07334707eafe238d5cb7b080a3ca796a1920
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FREM1 COL1A2 CRISPLD2 RARRES1 ZFPM2 GNA14 EPB41L2	3.87e-05	197	207	7	6d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	NEK6 DNAH14 COL1A2 HMCN1 MACF1 VPS13B SPATA13	3.87e-05	197	207	7	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PALD1 MERTK MNDA RHOB FCGR2C SCIN EPB41L2	3.99e-05	198	207	7	e1a0c809302a3b304775bd708201ad412a98d711
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MAP1B PFN2 CHN1 COL1A2 LRRC8E RARRES1 SCIN	3.99e-05	198	207	7	6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRMT8 EYA1 BMP6 FHIP1A CNTN4 SUSD4 GNA14	3.99e-05	198	207	7	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 CHN1 BMP6 SEMA6A VWF GNA14 EPHA4	3.99e-05	198	207	7	440af8f90c7afa1c07000806bcf9110b70f489fb
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FREM1 COL1A2 CRISPLD2 ZFPM2 HMCN1 IL1R1 EPB41L2	3.99e-05	198	207	7	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRMT8 EYA1 BMP6 FHIP1A CNTN4 SUSD4 GNA14	3.99e-05	198	207	7	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 CHN1 BMP6 SEMA6A VWF GNA14 EPHA4	3.99e-05	198	207	7	451003a21162eeae90739fdb502bb50b362d80c8
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PALD1 RABGAP1L MNDA RHOB FCGR2C SCIN EPB41L2	3.99e-05	198	207	7	cc808d872d2404a79ec119bb0be62688a30c93a7
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	STAG1 RABGAP1L KDM6A FHIP1A AMBRA1 WDFY3 VPS13B	3.99e-05	198	207	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	STAG1 RABGAP1L KDM6A UTY AMBRA1 WDFY3 VPS13B	4.12e-05	199	207	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	MAP1B COL1A2 CRISPLD2 ZFPM2 GNA14 IL1R1 EPB41L2	4.12e-05	199	207	7	9503646ff1ad248181146ce767e9d12e882ec3bd
Drug	Etofenamate [30544-47-9]; Down 200; 10.8uM; PC3; HT_HG-U133A	ZNF93 SETX PGAP1 RECK LRRC8E MED16 AMBRA1 FBXO11 IL1R1 ZNF839 EPHA4	1.83e-06	197	205	11	3989_DN
Drug	(R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; PC3; HT_HG-U133A	PGAP1 SUPT7L KDM6A IGSF3 ARHGEF12 LAMP1 FBXO11 IDH2 WDFY3 CDC42 VPS13B	1.93e-06	198	205	11	4259_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	EPHB3 RPS6KA2 ITPR1 RGL1 BMP6 MERTK IGSF3 DNMT3B CRISPLD2 RHOB	4.90e-06	177	205	10	7387_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A	RPS6KA2 RGL1 BMP6 MERTK PLK3 DNMT3B CRISPLD2 ARHGEF12 RHOB SCIN	5.15e-06	178	205	10	5940_UP
Drug	Nitrofural [59-87-0]; Down 200; 20.2uM; PC3; HT_HG-U133A	EPHB3 U2AF2 UNC45A CHM ITPR1 FBXL18 AP2B1 XPNPEP1 FCF1 GTF2I	9.59e-06	191	205	10	6721_DN
Drug	Amrinone [60719-84-8]; Up 200; 21.4uM; HL60; HT_HG-U133A	INTS1 CHN1 FBXL18 IGSF3 RARRES1 ADGRL1 LAMP1 ZFPM2 FSHB SCIN	1.20e-05	196	205	10	2724_UP
Drug	azafagomine	USP9X USP9Y TXNDC5 KDM6A ZFY FSHB	1.23e-05	57	205	6	CID011957435
Drug	Lynestrenol [52-76-6]; Down 200; 14uM; MCF7; HT_HG-U133A	CYP3A4 CAPN5 MERTK MED16 AMBRA1 ADGRL1 LAMP1 IDH2 WDFY3 IL1R1	1.31e-05	198	205	10	1537_DN
Drug	Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; PC3; HT_HG-U133A	SETX MAP1B RABGAP1L C2orf42 CAPN5 KDM6A RHOC MACF1 ZMYM4 RPAP2	1.37e-05	199	205	10	7148_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	EPHB3 ITPR1 RGL1 MERTK PLK3 DNMT3B CRISPLD2 RHOB EPHA4	2.83e-05	173	205	9	2105_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	EPHB3 RPS6KA2 ITPR1 RGL1 BMP6 MERTK DNMT3B CRISPLD2 RHOB	2.96e-05	174	205	9	2084_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A	RPS6KA2 RGL1 BMP6 CAPN5 DNMT3B CRISPLD2 RHOB EPB41L2 EPHA4	3.24e-05	176	205	9	7047_UP
Drug	Loestrin	CYP3A4 FCGR2B FCGR2C FSHB	3.39e-05	21	205	4	CID000062925
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	EPHB3 RGL1 BMP6 MERTK IGSF3 DNMT3B CRISPLD2 RHOB EPHA4	3.54e-05	178	205	9	4483_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A	EPHB3 RPS6KA2 UNC45A RGL1 BMP6 FBXL18 PLK3 CRISPLD2 TTC21B	4.21e-05	182	205	9	7503_UP
Drug	Hycanthone [3105-97-3]; Down 200; 11.2uM; HL60; HG-U133A	STAG1 RPS6KA2 UNC45A ITPR1 RGL1 RABGAP1L VPS13A MACF1 VPS13B	5.20e-05	187	205	9	1614_DN
Drug	MER-25	VPS13A MERTK IDH2	5.81e-05	9	205	3	CID000006222
Drug	Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; PC3; HT_HG-U133A	EPHB3 RPS6KA2 ITPR1 CLK1 ARHGEF12 FBXO11 WDFY3 IL1R1 CDC42	5.88e-05	190	205	9	5080_DN
Drug	Chlorzoxazone [95-25-0]; Up 200; 23.6uM; PC3; HT_HG-U133A	MAP1B UNC45A AP2B1 VPS35L DNMT3B MED16 LAMP1 IDH2 FCF1	6.91e-05	194	205	9	2100_UP
Drug	exoenzyme C3, Clostridium botulinum	COL1A2 RHOB RHOC CDC42	6.96e-05	25	205	4	ctd:C063007
Drug	Cisapride [81098-60-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	U2AF2 CHM ITPR1 CAPN5 AMBRA1 FCF1 GTF2I GRAMD1C EPB41L2	7.19e-05	195	205	9	6706_DN
Drug	Carisoprodol [78-44-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	USP19 VPS13A PLK3 ARHGEF12 AMBRA1 IDH2 ECPAS IL1R1 ZNF839	7.47e-05	196	205	9	6610_DN
Drug	Syrosingopine [84-36-6]; Down 200; 6uM; PC3; HT_HG-U133A	RECK CRISPLD2 LAMP1 GNA14 ZNF197 WDFY3 ZNF839 CDC42 VPS13B	7.47e-05	196	205	9	5733_DN
Drug	Delsoline [509-18-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A	PRMT8 INTS1 CHM CAPN5 MNDA ARHGEF12 AQP4 FSHB SIX2	7.77e-05	197	205	9	7212_UP
Drug	Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A	DDN AP2B1 SUPT7L UTY DNMT3B MED16 AMBRA1 CRIP1 EPB41L2	7.77e-05	197	205	9	1183_DN
Drug	9-aminoacridine	ACR DDN ITPR1 SARS1 SLC25A4 POLB	7.97e-05	79	205	6	CID000007019
Drug	dimethyl ditelluride	DDN SEMA6A	8.07e-05	2	205	2	CID000088493
Drug	RK-29	SARS1 SLC25A4	8.07e-05	2	205	2	CID000146774
Drug	Ornidazole [16773-42-5]; Down 200; 18.2uM; PC3; HT_HG-U133A	EPHB3 ZNF93 USP19 ARHGEF12 AMBRA1 LAMP1 GNA14 IL1R1 RPAP2	8.08e-05	198	205	9	5064_DN
Drug	Reserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A	ZNF93 SETX DDN IGSF3 WDFY3 IL1R1 ZNF839 GRAMD1C SIX2	8.08e-05	198	205	9	6603_DN
Drug	Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; HL60; HT_HG-U133A	CEP104 DDN RABGAP1L UTY PLK3 SLC25A4 MED16 MACF1 AGRN	8.08e-05	198	205	9	2714_DN
Drug	Guanethidine sulfate [60-02-6]; Down 200; 13.4uM; PC3; HT_HG-U133A	CYP3A4 PGAP1 MERTK MED16 ARHGEF12 IDH2 CDC42 GRAMD1C RPAP2	8.08e-05	198	205	9	5731_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; PC3; HT_HG-U133A	PGAP1 VPS35L KDM6A RALGDS MED16 FCF1 ORC5 PTP4A3 EPB41L2	8.08e-05	198	205	9	1806_UP
Drug	Scopoletin [92-61-5]; Down 200; 20.8uM; HL60; HT_HG-U133A	CYP3A4 FASTK PLK3 MED16 UBR4 LAMP1 CRIP1 PTP4A3 WDFY3	8.08e-05	198	205	9	3131_DN
Drug	Ornidazole [16773-42-5]; Up 200; 18.2uM; PC3; HT_HG-U133A	CHM ITPR1 SYCP2 AP2B1 MERTK AQP4 FCF1 CHST4 ZNF197	8.40e-05	199	205	9	2109_UP
Drug	Flucytosine [2022-85-7]; Down 200; 31uM; PC3; HT_HG-U133A	CEP104 DDN RABGAP1L VPS13A MED16 ADGRL1 FBXO11 ZNF197 GRAMD1C	8.73e-05	200	205	9	6690_DN
Drug	vinyl acetate	PFN2 IL31RA FANCL XPNPEP1	9.52e-05	27	205	4	CID000007904
Disease	Cohen syndrome (implicated_via_orthology)	VPS13C VPS13A VPS13B	2.84e-07	3	195	3	DOID:0111590 (implicated_via_orthology)
Disease	Intellectual Disability	STAG1 MAP1B LAMA1 AP1B1 TFB2M RALGDS KIF7 CTCF RLIM ACIN1 MACF1 CDC42 MAB21L1	9.67e-06	447	195	13	C3714756
Disease	malaria (implicated_via_orthology)	FCGR2B AQP4 FCGR2C	2.32e-05	9	195	3	DOID:12365 (implicated_via_orthology)
Disease	microvillus inclusion disease (implicated_via_orthology)	MYO5B CDC42	4.35e-05	2	195	2	DOID:0060775 (implicated_via_orthology)
Disease	Parkinson's disease 23 (implicated_via_orthology)	VPS13C VPS13A	4.35e-05	2	195	2	DOID:0060896 (implicated_via_orthology)
Disease	choreaacanthocytosis (implicated_via_orthology)	VPS13C VPS13A	4.35e-05	2	195	2	DOID:0050766 (implicated_via_orthology)
Disease	congenital diaphragmatic hernia (implicated_via_orthology)	FREM1 ZFPM2 KIF7	5.98e-05	12	195	3	DOID:3827 (implicated_via_orthology)
Disease	Kabuki syndrome (implicated_via_orthology)	KDM6A UTY	1.30e-04	3	195	2	DOID:0060473 (implicated_via_orthology)
Disease	autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology)	VPS13C VPS13A	1.30e-04	3	195	2	DOID:0111611 (implicated_via_orthology)
Disease	tacrolimus measurement	CYP3A7 CYP3A4	2.58e-04	4	195	2	EFO_0008458
Disease	congenital diaphragmatic hernia (is_implicated_in)	FREM1 ZFPM2	2.58e-04	4	195	2	DOID:3827 (is_implicated_in)
Disease	estrone conjugate measurement	CYP3A7 CYP3A4	2.58e-04	4	195	2	EFO_0007971
Disease	autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology)	SLC25A4 SLC25A5	2.58e-04	4	195	2	DOID:0111517 (implicated_via_orthology)
Disease	Congenital diaphragmatic hernia	FREM1 ZFPM2 IGF2R	3.46e-04	21	195	3	C0235833
Disease	tauro-beta-muricholate measurement	CYP3A7 CYP3A4	4.29e-04	5	195	2	EFO_0800213
Disease	glyco-beta-muricholate measurement	CYP3A7 CYP3A4	4.29e-04	5	195	2	EFO_0800569
Disease	plasminogen activator inhibitor 1 measurement	RPS6KA2 MOV10L1 UBR4 ZFPM2	4.52e-04	54	195	4	EFO_0004792
Disease	TEMPS-A questionnaire	EYA1 SHISA6 SLC35F2	5.87e-04	25	195	3	EFO_0004783
Disease	dehydroisoandrosterone sulfate DHEA-S measurement	CYP3A7 CYP3A4	6.40e-04	6	195	2	EFO_0021119
Disease	Leukemia, Myelomonocytic, Chronic	EZH2 KDM6A	6.40e-04	6	195	2	C0023480
Disease	androstenediol (3beta,17beta) monosulfate (1) measurement	CYP3A7 CYP3A4	6.40e-04	6	195	2	EFO_0800294
Disease	ulcerative colitis (implicated_via_orthology)	RHOB RHOC	8.93e-04	7	195	2	DOID:8577 (implicated_via_orthology)
Disease	X-24574 measurement	CYP3A7 CYP3A4	8.93e-04	7	195	2	EFO_0800897
Disease	venous thromboembolism, fibrinogen measurement	RAPGEF6 VWF ZFPM2 IL1R1	1.02e-03	67	195	4	EFO_0004286, EFO_0004623
Disease	peroxisomal biogenesis disorder (implicated_via_orthology)	RHOB RHOC	1.19e-03	8	195	2	DOID:0080377 (implicated_via_orthology)
Disease	cerebellar ataxia (implicated_via_orthology)	VPS13C VPS13A	1.19e-03	8	195	2	DOID:0050753 (implicated_via_orthology)
Disease	cleft palate (implicated_via_orthology)	CDC42 SIX2	1.19e-03	8	195	2	DOID:674 (implicated_via_orthology)
Disease	Leukemia, Megakaryoblastic, of Down Syndrome	EZH2 CTCF	1.19e-03	8	195	2	C1860789
Disease	esophagus squamous cell carcinoma (is_marker_for)	EZH2 BMP6 KDM6A DNMT3B	1.48e-03	74	195	4	DOID:3748 (is_marker_for)
Disease	breast cancer (is_marker_for)	BMP6 CCR6 KDM6A RHOB RHOC CTCF	1.49e-03	185	195	6	DOID:1612 (is_marker_for)
Disease	plexin-B2 measurement	FCGR2B FCGR2C	1.52e-03	9	195	2	EFO_0021867
Disease	thoracic aortic calcification measurement	VPS13A GNA14	1.52e-03	9	195	2	EFO_0010273
Disease	androstenediol (3beta,17beta) disulfate (1) measurement	CYP3A7 CYP3A4	1.52e-03	9	195	2	EFO_0800278
Disease	X-12063 measurement	CYP3A7 CYP3A4 DNAH14 BMP6 XPO4 PTP4A3	1.53e-03	186	195	6	EFO_0021283
Disease	4-androsten-3alpha,17alpha-diol monosulfate (3) measurement	CYP3A7 CYP3A4	1.89e-03	10	195	2	EFO_0022090
Disease	axin-2 measurement	ITIH1 MED16	1.89e-03	10	195	2	EFO_0801400
Disease	renal Wilms' tumor (is_implicated_in)	EZH2 SIX2	1.89e-03	10	195	2	DOID:5176 (is_implicated_in)
Disease	5alpha-androstan-3beta,17alpha-diol disulfate measurement	CYP3A7 CYP3A4	1.89e-03	10	195	2	EFO_0800289
Disease	DNA repair protein RAD51 homolog 4 measurement	CYP3A7 CYP3A4	2.30e-03	11	195	2	EFO_0801531
Disease	androstenediol (3beta,17beta) monosulfate (2) measurement	CYP3A7 CYP3A4	2.30e-03	11	195	2	EFO_0800295
Disease	5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement	CYP3A7 CYP3A4	2.75e-03	12	195	2	EFO_0800291
Disease	systemic lupus erythematosus (implicated_via_orthology)	FCGR2B POLB FCGR2C	2.89e-03	43	195	3	DOID:9074 (implicated_via_orthology)
Disease	Alcohol Use Disorder	NPY2R VWF FSHB	3.08e-03	44	195	3	C0001956
Disease	amyotrophic lateral sclerosis (biomarker_via_orthology)	AQP4 IGF2R	3.23e-03	13	195	2	DOID:332 (biomarker_via_orthology)
Disease	androstenediol (3alpha, 17alpha) monosulfate (3) measurement	CYP3A7 CYP3A4	3.23e-03	13	195	2	EFO_0800293
Disease	5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement	CYP3A7 CYP3A4	3.23e-03	13	195	2	EFO_0800284
Disease	X-21470 measurement	CYP3A7 CYP3A4	3.75e-03	14	195	2	EFO_0800817
Disease	malignant pleural mesothelioma (is_marker_for)	EZH2 KDM6A	3.75e-03	14	195	2	DOID:7474 (is_marker_for)
Disease	5alpha-androstan-3alpha,17alpha-diol monosulfate measurement	CYP3A7 CYP3A4	3.75e-03	14	195	2	EFO_0800283
Disease	autoimmune thrombocytopenic purpura (is_implicated_in)	FCGR2B DNMT3B	4.31e-03	15	195	2	DOID:8924 (is_implicated_in)
Disease	glycerate measurement	HMCN1 AGRN	4.31e-03	15	195	2	EFO_0021029
Disease	16a-hydroxy DHEA 3-sulfate measurement	CYP3A7 CYP3A4	4.31e-03	15	195	2	EFO_0800301
Disease	attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia	MRM2 ZFPM2 SLC35F2 IL1R1	4.59e-03	101	195	4	EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090
Disease	Synostotic Posterior Plagiocephaly	EZH2 FREM1	4.91e-03	16	195	2	C1833340
Disease	Craniosynostosis, Type 1	EZH2 FREM1	4.91e-03	16	195	2	C4551902
Disease	Acrocephaly	EZH2 FREM1	4.91e-03	16	195	2	C0030044
Disease	X-21410 measurement	CYP3A7 CYP3A4	4.91e-03	16	195	2	EFO_0800813
Disease	methylcobalamin deficiency type cblE, brain serotonin transporter measurement	VWF EPHA4	4.91e-03	16	195	2	EFO_0004569, MONDO_0009354
Disease	Trigonocephaly	EZH2 FREM1	4.91e-03	16	195	2	C0265535
Disease	Scaphycephaly	EZH2 FREM1	4.91e-03	16	195	2	C0265534
Disease	Synostotic Anterior Plagiocephaly	EZH2 FREM1	4.91e-03	16	195	2	C2931150
Disease	Metopic synostosis	EZH2 FREM1	4.91e-03	16	195	2	C1860819
Disease	andro steroid monosulfate C19H28O6S (1) measurement	CYP3A7 CYP3A4	4.91e-03	16	195	2	EFO_0800305
Disease	bipolar disorder	RPS6KA2 DDN ITIH1 CNTN4 MYOM3 CNKSR2 XPNPEP1 GNA14 PLXNA4 RPA1	5.25e-03	577	195	10	MONDO_0004985
Disease	Metastatic melanoma	RPS6KA2 PRKDC EPHA4	5.50e-03	54	195	3	C0278883
Disease	Brachycephaly	EZH2 FREM1	5.54e-03	17	195	2	C0221356
Disease	low affinity immunoglobulin gamma Fc region receptor II-a measurement	FCGR2B FCGR2C	5.54e-03	17	195	2	EFO_0021969
Disease	Ischemic stroke, fibrinogen measurement	RAPGEF6 STAG1 IL1R1	5.79e-03	55	195	3	EFO_0004623, HP_0002140
Disease	Leukemia, Myelocytic, Acute	DHX15 FANCL IDH2 GTF2I AGRN	5.97e-03	173	195	5	C0023467
Disease	estradiol measurement	CYP3A7 CYP3A4 PRMT9 FBXO11	6.19e-03	110	195	4	EFO_0004697
Disease	sphingosine 1-phosphate measurement	ITPR1 KDM6A	6.20e-03	18	195	2	EFO_0800185
Disease	Carcinoma of bladder	KDM6A EPHA4	6.20e-03	18	195	2	C0699885
Disease	5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement	CYP3A7 CYP3A4	6.20e-03	18	195	2	EFO_0800288

Protein segments in the cluster

Peptide	Gene	Start	Entry
YVCREGDIEKASTKL	TTC21B	256	Q7Z4L5
DKIKSHCFVTYSTVE	ACIN1	1046	Q9UKV3
FKCPKVEVESIAETY	C2orf42	471	Q9NWW7
CTRKISIAKSVFYIA	AQP4	106	P55087
CTAATEKQTLYKESR	GRAMD1C	396	Q8IYS0
SQDVYCIKSLIRKFT	CFAP61	21	Q8NHU2
REVKVYVCKSGRLTA	PRMT9	771	Q6P2P2
YVRKTAAVCVAKLHD	AP2B1	136	P63010
CDYASVEVSKLKRHI	CTCF	356	P49711
ITDYSISKRLADICK	EIF2AK4	441	Q9P2K8
IKVGKYVASEVCEES	DNMT3B	596	Q9UBC3
TFCEYTVIKEISVAK	ADH6	146	P28332
CKDSKESAYVVVGIT	ACR	246	P10323
TVKCKTIFLYHDSTD	ADAM7	586	Q9H2U9
RTCKDYIKAVVETVD	ADGRL1	611	O94910
ICKVSYASLADVDKA	ALDH1L2	471	Q3SY69
AIVAAVVALIYCRKK	FCGR2B	236	P31994
IIFCYERVASKVKER	GPR33	221	Q49SQ1
DGVTYSTECELKKAR	AGRN	721	O00468
TADKQYKGIIDCVVR	SLC25A5	46	P05141
RSCQSEKLIGYTKTV	CCR6	286	P51684
IAKVEKSDVGNYTCV	CNTN4	181	Q8IWV2
ECSSISDYSEKIIKA	PRMT8	141	Q9NR22
YVRKTAAVCVAKLHD	AP1B1	136	Q10567
ANSYVIIKCEGDKVR	CAPN5	536	O15484
NIYITEVKTGKCVHS	AMBRA1	76	Q9C0C7
KSRYECFHTLLTKEV	CCDC180	596	Q9P1Z9
IRFEDCSSAKTILKY	DHX15	221	O43143
IIYTKSVDVTEKLAC	DHX29	1231	Q7Z478
SKLLVIEVKTISCHY	DDN	31	O94850
CLEVYEKSKRTSLLA	CC2D2B	546	Q6DHV5
KCNKEVYFAERVTSL	CRIP1	6	P50238
HLKKVEESYTILCQR	ARHGEF12	1516	Q9NZN5
KIVKNVDRYCEAARS	CLK1	191	P49759
KDKTIQHVEVFCYAS	CHM	91	P24386
IEYCSIIKNKVTGES	RBM45	146	Q8IUH3
TETRTYHDVKEICKC	RUBCNL	286	Q9H714
LSEKKVISYRGCITQ	OR4N4C	86	A0A096LPK9
HTVSQYETCKIRTIK	RGL1	56	Q9NZL6
YETCKIRTIKAGTLE	RGL1	61	Q9NZL6
ISKVCRKEYENALFS	RECK	126	O95980
CIVYHLESKISKRIS	NPY2R	151	P49146
EIIICTYRQAKAAKE	PALD1	746	Q9ULE6
AVCTDRAFAVYAVTK	SLC16A8	246	O95907
ITDRARCKYSHKDIV	FASTK	391	Q14296
IDAAVCDKTTRKTYF	MMP27	376	Q9H306
KTVTSVLEECEQRKY	PARP15	386	Q460N3
DKFTRTCSSYAIEKI	PARP15	511	Q460N3
KCKRTEIITNYLSDH	nan	216	O00370
AYCSEVKASTTLDIK	MAP1B	1226	P46821
KLKTVRGVVTRYCSD	MOV10L1	36	Q9BXT6
YSCKHEEVIARRTKV	NGLY1	391	Q96IV0
STCGYKEVRLLAVQK	INTS1	356	Q8N201
LKVNCKVTSRFAHYV	ITIH1	56	P19827
TVCVADFGLSKKIYS	MERTK	736	Q12866
EYVIALRCAVKESKF	IL31RA	196	Q8NI17
LAVCTEGKNVYTEIK	ITPR1	1391	Q14643
CFIVLVKVKDSTEYT	ITPR1	2651	Q14643
SKCIKTVVFALYAHI	ARRDC5	216	A6NEK1
DVSYERSIIKCEKNG	ZFPM2	906	Q8WW38
AVRCYESLILKAEGK	KDM6A	76	O15550
REICVAIKTLKAGYT	EPHA4	646	P54764
KTVLVKECYSVFTNR	CYP3A4	91	P08684
KTVQCKVTLLDGTEY	EPB41L2	216	O43491
VFSVCKRIGYKVTFD	ENDOD1	481	O94919
YKIVAISCAADILKA	ECPAS	1631	Q5VYK3
VALIEFCYKSRAESK	GRIA3	841	P42263
KTCRQVYEFRVKESS	EZH2	461	Q15910
AIVAAVVALIYCRKK	FCGR2C	236	P31995
YTSKLVRLCKEDTAF	PLXNA4	276	Q9HCM2
KRKAFYTCASHVTVV	OR4A15	261	Q8NGL6
LSEKKVISYRGCITQ	OR4N4	86	Q8N0Y3
LSEKKVISYRSCITQ	OR4N5	86	Q8IXE1
VDLLAKDKTISYVGC	OR4S2	81	Q8NH73
VSKVKVQDLDCYTTV	CRISPLD2	381	Q9H0B8
IYSATKIGKESCFER	EYA1	526	Q99502
CYVHKSKVTVSSDRF	FREM1	1466	Q5H8C1
SEECLRKTSETVKYL	EEF1AKMT1	146	Q8WVE0
TRALLCKYFDKVVTL	KIF7	1096	Q2M1P5
FSEVYKATCLLDRKT	NEK6	56	Q9HC98
SLISVRAFYKKCAST	EPHB3	201	P54753
KVATQEGKEITCRSY	GGCT	111	O75223
YVEKISFLVACRVET	LRRC8E	276	Q6NSJ5
ARDLKAVKYVECSAL	CDC42	146	P60953
ITGVKLKEVECYSVQ	KBTBD7	446	Q8WVZ9
LKYIRKIGSFDETCT	PDPK2P	141	Q6A1A2
TEKSCYVLLAVISRK	OVOS2	1186	Q6IE36
QKTCTFKELVYETVR	FSHB	66	P01225
VLKNTISVKAVCDYR	MACF1	866	Q9UPN3
VFSCEIKEAVSRILY	RABGAP1L	231	Q5R372
ICVATSVAGEKEIKY	HMCN1	1711	Q96RW7
FYKVCVSVVSEKCRI	MED16	241	Q9Y2X0
LGAKKCSVIRDSLYV	PFN2	66	P35080
VYVPTEDVKRISKEC	NLGN3	146	Q9NZ94
GICKSYEDATKITVR	RPA1	321	P27694
RKSQKETESLHCEYV	ERVK-5	121	Q9HDB9
LETAKAVKERYSYVC	ACTR3	221	P61158
SRFTYTVLVDGCSKK	COL1A2	1306	P08123
TGCKARELKSVYVDA	CEP104	106	O60308
KERDCYSVSAAKLLA	FHIP1A	426	Q05DH4
KYSVAVKCATITPDE	IDH2	106	P48735
SGKYNCRVTEREKTV	IGSF3	371	O75054
VYEFSTTKKHLAECL	ICE1	1956	Q9Y2F5
AQSLFVKECIKTYST	DOCK11	96	Q5JSL3
ISEIEKRYDICSKVS	DTX3L	396	Q8TDB6
HDYTSVCLKLIKVFV	ARV1	201	Q9H2C2
KYTTIKDLTAELREC	CCDC18	981	Q5T9S5
QHKCYIVATVDRDLK	FCF1	151	Q9Y324
IEKAVSRGQCLYKIS	FBXO11	826	Q86XK2
KASTECVKFYIHAIG	FAM111A	176	Q96PZ2
SELKTACRKHELYVS	BMP6	406	P22004
FEIVKAIKERACYLS	ACTR1A	211	P61163
SVKVYKLGIFSVVSC	DTHD1	286	Q6ZMT9
CVKSFVSSYSREKLE	DNAH14	1026	Q0VDD8
VAQAVDKCSYRDVVK	MAB21L2	136	Q9Y586
NLYETCKVRTVKAGT	RALGDS	106	Q12967
SITDIRADIDKKYRC	LAMP1	141	P11279
KTVLVKECYSVFTNR	CYP3A7	91	P24462
ILRAVADKGTCKYVS	H1-9P	121	P60008
HVKKVYSCDLTTLVK	CHN1	261	P15882
PIATRVKCAVKDTYS	DEFB133	16	Q30KQ1
RTTCKESEVYYILCK	DEFB121	31	Q5J5C9
ELAKSKAEVACIAVY	GTF2IRD2	36	Q86UP8
ELAKSKAEVACIAVY	GTF2IRD2B	36	Q6EKJ0
ELAKSKAEVACIAVY	GTF2I	36	P78347
CSSKPRVEYSTKIVE	SLFN13	286	Q68D06
RVEYSTKIVEVFCGK	SLFN13	291	Q68D06
VKKVDSEYIATVCGS	POLB	166	P06746
SSYCLRIKISAKFVE	IL1R1	101	P14778
VSKFCKYEHDDIVST	WDR77	116	Q9BQA1
YLECSAKTKEGVREV	RHOC	156	P08134
VRKKVITISDYSECK	MNDA	261	P41218
KEKVIYSHFTCATDT	GNA14	316	O95837
GKSYEECIIESRAKL	IGF2R	1911	P11717
ERYCKTTDVLTIKTD	MRPS35	196	P82673
DCTVRKKYSHVDLVV	SARS1	161	P49591
VRTSYVKKIIEDCSN	USP9X	2281	Q93008
GKAVRCYESLILKAE	UTY	71	O14607
YLECSAKTKEGVREV	RHOB	156	P62745
QSCYIIISKDTTAKE	RAPGEF6	761	Q8TEU7
TYTLKAFTVGSKCVV	TDRD6	2021	O60522
YSIKCFDTVTKELVS	TBC1D31	106	Q96DN5
LDIAYKFGKTVVSCE	SARAF	101	Q96BY9
LVYADTCFSTIKLKA	FANCL	126	Q9NW38
VAQAVDKCSYRDVVK	MAB21L1	136	Q13394
TARITCSGDVLAKKY	IGLV3-27	36	P01718
AEYVASVLKCKTLRI	SCIN	566	Q9Y6U3
HFRVCSDITLYKAKT	FAM183A	111	A6NL82
KYKCTVSLDFIRAIA	ORC5	406	O43913
VKTTCVYRVLFKNLD	FBXL18	731	Q96ME1
IKVAVSADRDCIRAY	LAMA1	2116	P25391
EKKFTEISHRILCSY	RNF32	226	Q9H0A6
AIIKTCDKNYRHDAV	SETX	2446	Q7Z333
KDKTNFTVYITCGVI	SHISA6	171	Q6ZSJ9
KTLFETIERSKDCAY	TFB2M	371	Q9H5Q4
SKCSAVKEEITSIYR	PGAP1	511	Q75T13
VKRAVVYLDAACAES	SCFD2	21	Q8WU76
TLTDVAHEYCLKFTK	SUPT7L	181	O94864
ISNVCEEYIVKKLSR	SLC35F2	211	Q8IXU6
SAEKQYKGIIDCVVR	SLC25A4	46	P12235
FEVVEKACRSYSHVV	CHST4	161	Q8NCG5
KACRSYSHVVLKEVR	CHST4	166	Q8NCG5
TVYETENKILHVCKT	CNKSR2	176	Q8WXI2
DCTVYKADVARLVAR	ATG4D	276	Q86TL0
VSRTTDEVYLFCAKK	SPATA13	531	Q96N96
ETADLKETYRCIKQV	PLK3	261	Q9H4B4
EECGKAFKYSRILTT	ZNF93	316	P35789
FYAEIKSSCAKVQTR	USP19	166	O94966
AVTYKVAISFDRCKI	ZSWIM5	216	Q9P217
EKTYECHVCRKVLTS	ZNF197	871	O14709
LQVSDTATYECRVKK	VSIG8	116	P0DPA2
DLKKYGATTVVRVCE	PTP4A3	36	O75365
KECFTYVLKGHIAVS	XPNPEP1	441	Q9NQW7
FAVCKHILETSKVDY	XPO4	51	Q9C0E2
DIKYRKVRDGCVTDA	VPS13A	1486	Q96RL7
EYTCKHFTKREVNTV	VPS35L	511	Q7Z3J2
CKYEERSSVTIKVTI	TMEM9B	91	Q9NQ34
CSIFAYEDIKEVHKR	WDFY3	2606	Q8IZQ1
DITARLQYVKVGSCK	VWF	2726	P04275
LQYVKVGSCKSEVEV	VWF	2731	P04275
EKYNCKVTVIDRGTL	TCEANC	301	Q8N8B7
HYSDVVDERSIVKLC	RPAP2	86	Q8IXW5
IDTSHTEEIYCSKKL	SEMA6A	81	Q9H2E6
SEYSTVLVLCYRKTK	SPANXN5	46	Q5MJ07
YRKLKTTFVNVTSEC	SYCP2	851	Q9BX26
SVCITEYTEGNKLRK	RLIM	571	Q9NVW2
EKLIITCHEGFKIRY	SUSD4	141	Q5VX71
AIKKHLYSTRNVVAC	MRPL18	111	Q9H0U6
KAFVCRSYVAKHTRI	ZNF808	686	Q8N4W9
VIKGQERAVACSKYE	SLU7	406	O95391
KHVESDVLEACSKTY	STAG1	626	Q8WVM7
GCVRKVYLKDTATAE	VPS13C	3706	Q709C8
ATKFKCHDVVIDTYR	VIPAS39	441	Q9H9C1
FVRTSYVKKIIEDCS	USP9Y	2281	O00507
RTLTVEGCEYKKIHQ	PSME4	951	Q14997
AAKVESYRCRSAFKL	MRM2	46	Q9UI43
ETSYCFKEKSRSVLR	SIX2	126	Q9NPC8
EIKNTCTSVYTKDRA	PRKDC	106	P78527
KILSVDSVAVDCAYR	ZNF839	686	A8K0R7
CRKTFYDKTVLTIHQ	ZNF717	791	Q9BY31
DVRDECSKYGLVKSI	U2AF2	401	P26368
VKCKIESFNIDHYRS	VPS13B	1371	Q7Z7G8
DAKVYVAKVDCTAHS	TXNDC5	111	Q8NBS9
TLERKCEKRSVYIDA	ZC3H15	126	Q8WU90
CRKIIYLNTDFVSVK	ZNF674	126	Q2M3X9
STTKCSSVKYDVEIV	UBR4	1076	Q5T4S7
VTSVKDAKIAVYSCP	CCT8	231	P50990
KEGCKVHVVFSTERY	RARRES1	96	P49788
LTTHKIICAEEKLYR	ZNF726P1	61	Q15940
YVHSALKIFKTAEEC	USP8	36	P40818
YKCSEKDSIRIRALV	UNC45A	486	Q9H3U1
RVEYLGSKKEVQTCL	TIPIN	126	Q9BVW5
YCKIEKIVKETVRFS	ZMYM4	731	Q5VZL5
STCPEVIKVYIFKAD	ZFY	241	P08048
FVTSTVKKVYRPEDC	WDR64	676	B1ANS9
RCVHKATDTEYAVKI	RPS6KA2	431	Q15349
KHFSVKGDVYICLTR	LGI1	436	O95970
LCHRKLVTTSETYVK	MYO5B	376	Q9ULV0
RQASLKVSCTYKEDE	MYOM3	326	Q5VTT5